NGEN NervGen Pharma Corp

Watchlist

15min DelayMarket Closed Jun 28 16:00 ET

188.11MMarket Cap-7911P/E (TTM)

NervGen Pharma Corp Key Stats

Currency: CAD

Period

Q1 FY2024 Earnings

Revenue(YoY)

0.00

0.00%

EPS(YoY)

-0.04

+50.00%

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2022/Q4	0.000 / 0.000	--
--	2022/Q3	0.000 / 0.000	--
--	2022/Q2	0.000 / 0.000	--
--	2021/Q4	0.000 / 0.000	--
--	2021/Q3	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2022/Q40.000 / 0.000--

--2022/Q30.000 / 0.000--

--2022/Q20.000 / 0.000--

--2021/Q40.000 / 0.000--

--2021/Q30.000 / 0.000--

Overall